Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 4/20 | 0.43 |
| ▸ | ACACB | O00763 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8294303 | 0.87 | F2 (0.52) | SLC7A5DPP4OPRD1HDAC8F2 | |
| SCHEMBL10435928 | 0.80 | SLC7A5 (0.62) | SLC7A5DPP4HDAC8TAAR1SLC6A2 | |
| Hydrochloric Acid SCHEMBL6165185 | 0.79 | SLC7A5 (0.61) | SLC7A5DPP4HDAC8TAAR1SLC6A2 | |
| Hydrochloric Acid SCHEMBL6165180 | 0.79 | SLC7A5 (0.61) | SLC7A5DPP4HDAC8TAAR1SLC6A2 | |
| SCHEMBL7983865 | 0.77 | F2 (0.45) | F2 | |
| SCHEMBL21319341 | 0.76 | SLC7A5 (0.57) | SLC7A5DPP4OPRD1HDAC8TAAR1 | |
| SCHEMBL25083941 | 0.75 | SLC7A5 (0.56) | SLC7A5HDAC8TAAR1SLC6A2 | |
| SCHEMBL2015826 | 0.74 | SLC7A5 (0.59) | SLC7A5DPP4OPRD1HDAC8TAAR1 | |
| SCHEMBL2015825 | 0.74 | SLC7A5 (0.59) | SLC7A5DPP4OPRD1HDAC8TAAR1 | |
| SCHEMBL30440024 | 0.74 | SLC7A5 (0.58) | SLC7A5OPRD1HDAC8TAAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005025554-A2 | DIPEPTIDYL PEPTIDASE IV INHIBITOR | JAPAN TOBACCO INC. (JP) | 2005-03-24 | — | — | WO | disclosed |